Journal ArticleOPEN ACCESS

Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes

  • Holman R
  • Thorne K
  • Farmer A
  • et al.
New England Journal of Medicine (2007) 357(17) 1716-1730
DOI: 10.1056/nejmoa075392
657Citations
Citations of this article
325Readers
Mendeley users who have this article in their library.

Abstract

Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though evidence supporting specific insulin regimens is limited.

Cite

CITATION STYLE

APA

Holman, R. R., Thorne, K. I., Farmer, A. J., Davies, M. J., Keenan, J. F., Paul, S., & Levy, J. C. (2007). Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. New England Journal of Medicine, 357(17), 1716–1730. https://doi.org/10.1056/nejmoa075392

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free